Cargando...
Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells
Sorafenib is currently the standard chemotherapy drug for treatment of advanced hepatocellular carcinoma (HCC). But its efficacy requires improvement, it is imperative to seek therapeutic strategies that combine sorafenib with other anticancer agents. In this study we investigated the synergistic an...
Gardado en:
| Publicado en: | Acta Pharmacol Sin |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer Singapore
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7921114/ https://ncbi.nlm.nih.gov/pubmed/32300243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-020-0395-5 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|